SCHEMBL9584197

SCHEMBL9584197

CCc1c(C(=O)c2ccccc2)ncc2[nH]c3cc(OC)c(OC)cc3c12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 16/20 0.71
▸ GABRA5 P31644 16/20 0.71
▸ GABRA3 P34903 16/20 0.71
▸ GABRA2 P47869 15/20 0.71
▸ GABRG2 P18507 14/20 0.71
▸ GABRB3 P28472 14/20 0.71
▸ GABRA6 Q16445 9/20 0.71
▸ GABRB2 P47870 6/20 0.71
▸ ALDH1A1 P00352 2/20 0.71
▸ MAPT P10636 2/20 0.71
▸ KDM4E B2RXH2 1/20 0.71
▸ GMNN O75496 1/20 0.71
▸ LMNA P02545 1/20 0.71
▸ CYP1A2 P05177 1/20 0.71
▸ POLB P06746 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ NFKB1 P19838 1/20 0.71
▸ APEX1 P27695 1/20 0.71
▸ MAPK1 P28482 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7552127 0.87 GABRA1 (0.80) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL29369769 0.83 GABRA1 (1.00) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL22680192 0.83 GABRA1 (0.79) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL472510 0.83 GABRA1 (1.00) GABRA1GABRA5GABRA3GABRA2GABRG2
Hydrochloric Acid SCHEMBL19694788 0.82 GABRA1 (0.98) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL9838934 0.81 GABRA1 (1.00) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL9083956 0.81 GABRA1 (1.00) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL22680193 0.77 GABRA1 (0.79) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL9584255 0.77 GABRA1 (0.69) GABRA1GABRA5GABRA3GABRA2GABRG2
SCHEMBL9584762 0.77 GABRA1 (0.45) GABRA1GABRA5GABRA3GABRA2GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5254563-A Bioavailability; central nervous system disorders SCHERING AKTIENGESELLSCHAFT (DE) 1993-10-19 — — US disclosed
Send feedback